Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn
Research ArticleArticle

An Alkylating Derivative of Benzilylcholine with Specific and Long-Lasting Parasympatholytic Activity

E. W. GILL and H. P. RANG
Molecular Pharmacology July 1966, 2 (4) 284-297;
E. W. GILL
University Department of Pharmacology, South Parks Road, Oxford, England
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
H. P. RANG
University Department of Pharmacology, South Parks Road, Oxford, England
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • eLetters
  • PDF
Loading

Abstract

Benzilylcholine mustard (N-2-chloroethyl-N-methyl 2-aminoethyl benzilate), a 2-haloalkylamine which cyclizes in solution to form an ethyleniminium derivative structurally very similar to benzilylcholine, was found to be a potent antagonist of the muscarinic action of acetylcholine. It differed from benzilylcholine in showing a much greater persistence of action, which was attributed to the alkylating activity of the ethyleniminium ion. Its action was highly specific, antagonism of the action of histamine and noradrenaline on smooth muscle requiring about 1000 times the concentration needed to block acetylcholine. It did not block ganglionic or neuromuscular transmission, but inhibited parasympathetic effects as well as the muscarinic actions of exogenous acetylcholine.

Blocking activity was confined to the ethyleniminium ion: neither the 2-chloroethyl-amine nor the alcoholic hydrolysis product was active.

In a study of the rate constants relating to the interaction of benzilylcholine and benzilylcholine mustard with acetylcholine receptors in guinea pig intestinal muscle, it was found that the association rate constant was similar for the two compounds, but that dissociation following alkylation by benzilylcholine mustard occurred at only [unknown] of the rate at which benzilylcholine dissociates. The complex initially formed by benzilylcholine mustard was a reversible one, but alkylation occurred rapidly, the rate of alkylation being considerably greater than that of dissociation of the reversible complex.

ACKNOWLEDGMENT The analog computer used in this study was obtained by means of a grant from the Medical Research Council.

  • Copyright ©, 1966, by Academic Press Inc.

MolPharm articles become freely available 12 months after publication, and remain freely available for 5 years. 

Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page. 

 

  • Click here for information on institutional subscriptions.
  • Click here for information on individual ASPET membership.

 

Log in using your username and password

Forgot your user name or password?

Purchase access

You may purchase access to this article. This will require you to create an account if you don't already have one.
PreviousNext
Back to top

In this issue

Molecular Pharmacology
Vol. 2, Issue 4
1 Jul 1966
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Editorial Board (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Molecular Pharmacology article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
An Alkylating Derivative of Benzilylcholine with Specific and Long-Lasting Parasympatholytic Activity
(Your Name) has forwarded a page to you from Molecular Pharmacology
(Your Name) thought you would be interested in this article in Molecular Pharmacology.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleArticle

An Alkylating Derivative of Benzilylcholine with Specific and Long-Lasting Parasympatholytic Activity

E. W. GILL and H. P. RANG
Molecular Pharmacology July 1, 1966, 2 (4) 284-297;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleArticle

An Alkylating Derivative of Benzilylcholine with Specific and Long-Lasting Parasympatholytic Activity

E. W. GILL and H. P. RANG
Molecular Pharmacology July 1, 1966, 2 (4) 284-297;
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • The binding site for KCI807 in the androgen receptor
  • Fatty acid amide hydrolase in cisplatin nephrotoxicity
  • eCB Signaling System in hiPSC-Derived Neuronal Cultures
Show more Articles

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics